1. - Clinica malattie apparato respiratorio

IL VOLTO DELLA BPCO CHE CAMBIA ● QUADERNO 6
17. Mahler DA,Tomlinson D,Olmstead EM et al:Changes
in dyspnea, health status, and lung function in
chronic airway disease Am J Respir Crit Care Med
1995; 151:61-65.
18. Wijkstra PJ e Jones PW: Quality of life in patients
with chronic obstructive pulmonary disease. In Postma
DS e Siafakas NM (eds): Management of chronic
obstructive pulmonary disease. Eur Respir
Monograph, Sheffiled, UK, 1998:235-246.
19. Jones PW, Quirk FH, Baverystock CM et al:A selfcompleted
measure for chronic airflow limitation -
the St. George’s Respiratory Questionnaire. Am
Rev Respir Dis 1992; 145:1321-1327.
20. Jones PW: Interpreting thresholds for a clinically significant
change in health status in asthma and
COPD. Eur Respir J 2002; 19:398-404.
21. Jones PW e Bosh TK: Quality of life changes in
COPD patients treated with salmeterol. Am J Respir
Crit Care Med 1997; 155:1283-1289.
22. Burge PS, Calverly PMA, Jones PW et al: Randomised,
double-blind, placebo controlled study of
fluticasone propionate in patients with moderate to
severe chronic obstructive pulmonary disease: the
ISOLDE trial. BMJ 2000; 320:1297-1303.
23. Lacasse Y,Brusseau L,Milne S et al:Pulmonary rehabilitation
for chronic obstrcutive pulmonary disease.
Cochrane Database Syst Rev 2002; CD003793.
24. Housset B, Jones PW, Paggiaro PL et al: Development
of a primary-care tool to further define treatment
success in COPD. Consensus report from a
closed meeting of respiratory and primary-care specialists.
PCRJ 2003 (submitted). In stampa.
25. Van Noord JA, de Munck DRAJ, Bantje T et al:
Long-term treatment of chronic obstructive pulmonary
disease with salmeterol and the additive effect
of ipratropium. Eur Respir J 2000; 15:878-885.
26. Donaldson GC, Seemungal TA, Bhowmik A et al:
Relationship between exacerbation frequency and
lung function decline in chronic obstructive pulmonary
disease.Thorax 2002; 57:847-852.
27. Diaz O,Villafranca C, Ghezzo H et al: Role of inspiratory
capacity on exercise tolerance in COPD
patients with and without tidal expiratory flow limitation
at rest. Eur Respir Dis 2000; 16:269-275.
28. O’Donnell DE, Revill SM,Webb KA: Dynamic hyperinflation
and exercise intolerance in chronic obstructive
pulmonary disease. Am J Respir Crit Care
Med 2001; 164:770-771.
29. Duranti R, Filippelli M, Bianchi R et al: Inspiratory
capacity and decrease in lung hyperinflation with
albuterol in COPD. Chest 2002; 122:2009-2014.
30. Tantucci C, Duguet A, Similowski T et al: Effect of
salbutamol on dynamic hyperinflation in chronic
obstructive pulmonary disease patients. Eur Respir
J 1998; 12:799-804.
31. Anthonisen NR, Connett JE, Kiley JP et al: Effects
of smoking intervention and the use of an inhaled
anticholinergic bronchodilator on the rate of decline
of FEV 1 .The Lung Health Study. JAMA 1994;
272:1497-1505.
32. Pauwels RA, Löfdahl CG, Laitinen LA et al: Longterm
treatment with inhaled budesonide in persons
with mild chronic obstructive pulmonary disease
who continue smoking. N Engl J Med 1999;
340:1948-1953.
33. Burge PS, Calverley PM, Jones PW et al: Randomized,double
blind,placebo controlled study of fluticasone
propionate in patients with moderate to
severe chronic obstructive pulmonary disease: the
ISOLDE trial. BMJ 2000; 320:1297-1303.
34. The Lung Health Study Research Group: Effect of
inhaled triamcinolone on the decline in pulmonary
function in chronic obstructive pulmonary disease.
N Engl J Med 2000; 343:1902-1909.
35. Belman MJ, Botnick WC, Shin JW: Inhaled bronchodilators
reduce dynamic hyperinflation during
exercise in patients with chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 1996;
153:967-975.
36. O’Donnell DE,Lam M,Webb KA:Spirometric correlates
of improvement in exercise performance after
anticholinergic therapy in chronic obstructive
pulmonary disease. Am J Respir Crit care Med
1999; 160:542-549.
37. Boni E, Corda L, Franchini D et al:Volume effect
and exertional dyspnoea after bronchodilator in patients
with COPD with and without expiratory
flow limitation at rest. Thorax 2002; 57:528-532;
1994; 93:200-205.
38. Singh SJ, Morgan MDL, Scott S et al: Developments
of a shuttle walking test of disability in patients
with chronic airways obstruction. Thorax
1992; 47:1019-1024.
39. Singh SJ, Morgan MDL, Hardman AE et al: Comparison
of oxygen uptake during a conventional
treadmill test and the shuttle walking test in chronic
airflow limitation. Eur Respir J 1994; 7:2016-2020.
40. Liesker JJW,Wijkstra PJ,Ten Hacken NHT et al: A
systematic review of the effects of bronchodilators
on exercise capacity in patients with COPD. Chest
2002; 121:597-608.
12